Hepatocellular Carcinoma
Conditions
Brief summary
The purpose of the study is to observe the curative effect and safety of laparoscopic versus open liver resection for hepatocellular carcinoma.
Detailed description
Liver resection is the most important treatment of hepatocellular carcinoma (HCC). Open hepatectomy was regarded as a giant surgery because of its big incision, influence of the liver function, and long hospital stay. Laparoscopic hepatectomy was widely used since it was reported by Reich in 1991. With the constant innovation of laparoscopic technique and equipment, there is no penalty area in laparoscopic hepatectomy. The Louisville consensus proposed that the best indication for laparoscopic hepatectomy was the tumor diameter \< 5cm, located in segment II-VI. Previous studies shows that compared with the open surgery, laparoscopic hepatectomy has the advantages of shorter operation time, less bleeding, shorter hospitalization time. The mortality, mobility, the overall survival and the disease-free survival was same in these two groups. So far, however, the curative effect and safety research of laparoscopic versus open liver resection for HCC is limited to retrospective study and case-control study. A prospective, randomized, controlled study is urgently needed. This study was proceeded to observe the curative effect and safety of laparoscopic versus open liver resection for HCC.
Interventions
PROCEDURElaparoscopic hepatectomy
The HCC patients who meet the Louisville consensus will underwent liver resection by laparoscopy
PROCEDUREOpen hepatectomy
The HCC patients who meet the Louisville consensus will underwent liver resection by open surgery
Sponsors
Fudan University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. Diagnosis was HCC 2. The tumor was located in segment: II, III, IVb, V, VI 3. The tumor diameter \< 5cm 4. Without thrombosis in the portal vein, hepatic vein or bile duct 5. Without intrahepatic and systemic metastasis 6. The Child-pugh score was A-B7 7. The ASA（American Society of Anesthesiologists） score was I-III 8. The patient age was between 18-75 9. Sign the informed consent, and can fully understand the research content
Exclusion criteria
1. Have surgery contraindications 2. Pregnant or lactating women 3. The Child-pugh score was B8-C 4. The ASA（American Society of Anesthesiologists） score was IV-V 5. With other malignant tumor 6. With mental illness 7. Participated in other clinical trials in the last three months 8. Underwent other treatments(chemotherapy or radiotherapy) before operation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall survival | 5 years | The overall survival of HCC patients after operation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Disease free survival | 5 years | The disease free survival of HCC patients after operation |
| Incidence of postoperative complications | 1 month | Incidence of postoperative complications |
Countries
China
Outcome results
None listed